Inari Medical, Inc. (NARI) Tops Q2 EPS by 17c

Inari Medical, Inc. (NASDAQ: NARI) reported Q2 EPS of $0.04, $0.17 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $119 million versus the consensus estimate of $116.75 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Four key things investors will watch in Nvidia's earnings next week
• New York City REIT Inc. (NYC) Reports Q2 Loss of $3.04
• National Vision (EYE) Tops Q2 EPS by 7c; Offers Guidance